About Zivo Bioscience
Zivo Bioscience is a company based in Keego Harbor (United States) founded in 1983.. Zivo Bioscience has raised $962 thousand across 20 funding rounds from investors including Health Enterprise Partners. The company has 7 employees as of December 31, 2024. Zivo Bioscience offers products and services including Algal Biomass Extract and Bioactive Compounds. Zivo Bioscience operates in a competitive market with competitors including Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others.
- Headquarter Keego Harbor, United States
- Employees 7 as on 31 Dec, 2024
- Stage Public
-
Sectors
HealthcareAgriculture
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Zivo Bioscience, Inc.
-
Annual Revenue
$157.22 K468.61as on Dec 31, 2024
-
Net Profit
$-13.38 M-72.1as on Dec 31, 2024
-
EBITDA
$-13.36 M-83.97as on Dec 31, 2024
-
Total Equity Funding
$962 K (USD)
in 20 rounds
-
Latest Funding Round
$4 M (USD), Post-IPO
Jun 30, 2023
- Investors
-
Employee Count
7
as on Dec 31, 2024
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Zivo Bioscience
Zivo Bioscience is a publicly listed company on the OTC with ticker symbol ZIVO in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Products & Services of Zivo Bioscience
Zivo Bioscience offers a comprehensive portfolio of products and services, including Algal Biomass Extract and Bioactive Compounds. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Extract for enhancing immune response in animals and human health.
Compounds supporting muscle recovery and joint health in humans.
Unlock access to complete
Leadership Team
3 people
Product Management Team
2 people
Finance and Accounting
1 people
Senior Team
1 people
Unlock access to complete
Funding Insights of Zivo Bioscience
Zivo Bioscience has successfully raised a total of $962K across 20 strategic funding rounds. The most recent funding activity was a Post-IPO round of $4 million completed in June 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 20
- Last Round Post-IPO — $4.0M
-
First Round
First Round
(21 Sep 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Post-IPO - Zivo Bioscience | Valuation |
investors |
|
| Oct, 2016 | Amount | Post-IPO - Zivo Bioscience | Valuation |
investors |
|
| Mar, 2014 | Amount | Post-IPO - Zivo Bioscience | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Zivo Bioscience
Zivo Bioscience has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Health Enterprise Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are focused on healthcare and information technology sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Zivo Bioscience
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Zivo Bioscience
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Zivo Bioscience Comparisons
Competitors of Zivo Bioscience
Zivo Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Avidity Biosciences, Univercells, Sutro Biopharma, Vividion Therapeutics and Straumann Group, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Biomanufacturing technologies are supplied for biopharma antibody and vaccine production.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Developing novel drugs based on a proteome-wide ligand and target discovery platform
|
|
| domain | founded_year | HQ Location |
Dental implants and regenerative dentistry products are developed.
|
|
| domain | founded_year | HQ Location |
RNA-editing technologies are provided for precision medicine applications.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Zivo Bioscience
Frequently Asked Questions about Zivo Bioscience
When was Zivo Bioscience founded?
Zivo Bioscience was founded in 1983 and raised its 1st funding round 26 years after it was founded.
Where is Zivo Bioscience located?
Zivo Bioscience is headquartered in Keego Harbor, United States. It is registered at Keego Harbor, Michigan, United States.
Is Zivo Bioscience a funded company?
Zivo Bioscience is a funded company, having raised a total of $962K across 20 funding rounds to date. The company's 1st funding round was a Post-IPO of $100K, raised on Sep 21, 2009.
How many employees does Zivo Bioscience have?
As of Dec 31, 2024, the latest employee count at Zivo Bioscience is 7.
What is the annual revenue of Zivo Bioscience?
Annual revenue of Zivo Bioscience is $157.22K as on Dec 31, 2024.
What does Zivo Bioscience do?
Zivo Bioscience was founded in 1983 in Keego Harbor, United States, within the biotechnology sector. A patented platform is utilized for extracting bioactive molecules from algal biomass. Byproduct extracts are combined with other ingredients to produce supplements and food items, while high-value components such as nutrients and proteins are isolated. Initial market entry is targeted at nutritional products, followed by expansion into pharmaceuticals and medicinal applications.
Who are the top competitors of Zivo Bioscience?
Zivo Bioscience's top competitors include Sutro Biopharma, Synthego and Avidity Biosciences.
What products or services does Zivo Bioscience offer?
Zivo Bioscience offers Algal Biomass Extract and Bioactive Compounds.
Is Zivo Bioscience publicly traded?
Yes, Zivo Bioscience is publicly traded on OTC under the ticker symbol ZIVO.
Who are Zivo Bioscience's investors?
Zivo Bioscience has 1 investor. Key investors include Health Enterprise Partners.
What is Zivo Bioscience's ticker symbol?
The ticker symbol of Zivo Bioscience is ZIVO on OTC.